Navigation Links
CONRAD to host HIV symposium at 2nd Annual Antivirals Congress
Date:11/5/2012

Arlington, VA CONRAD HIV and microbicides experts will be featured at the 2nd Annual Antivirals Congress organized by Elsevier publications. This year's conference is being held on November 11-13 at the Boston Marriott Cambridge. Executive and Scientific Director Gustavo Doncel and Director of Product Development David Friend will discuss ex vivo models for testing topical antiviral microbicides and current antiretroviral based microbicide products.

Other speakers at the CONRAD symposium include Tom Hope from Northwestern University and Patrick Kiser from the University of Utah who will speak on defining the interaction of HIV and the mucosal barriers exposed during sexual transmission, and novel microbicide dosage forms to prevent HIV transmission, respectively.

What: CONRAD Symposium: The Use of Antiviral Agents to Prevent HIV Transmission

When and Where: Monday, November 12th 2:00-3:40PM Boston Marriott Cambridge

CONRAD, a not for profit scientific organization based in Arlington, Virginia, specializes in developing new contraceptive methods and products to prevent or reduce HIV and other sexually transmitted infections. Several products in the pipeline focus on multi-purpose prevention options which provide contraception as well as HIV and STI protection. CONRAD tested and developed tenofovir gel, the first drug to show proof of concept that a vaginal gel containing antiretrovirals can reduce HIV and HSV-2 infections when used before and after sex.

Tenofovir is a drug commonly used by those infected with HIV to prevent the virus from multiplying in the immune system. A clinical study of women in South Africa who used a vaginal gel containing tenofovir has shown that it is 40-54 percent effective in reducing sexual transmission when used before and after sex.

The Antiretrovirals Congress provides state-of-the-art reports for scientists, health professionals and non governmental authorities to accelerate progress in the development and application of antivirals. The Congress serves as an interface between different interest groups from academia, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals.


'/>"/>

Contact: Annette Larkin
alarkin@conrad.org
703-772-6427
CONRAD
Source:Eurekalert

Related medicine news :

1. Triple negative breast cancer symposium highlights current advances
2. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
3. Kessler Foundation scientists present cognitive research findings at MS dual symposium
4. fiteBac™ SkinCare, LLC Participates in OSAP Symposium on Infection Control
5. International symposium on veterinary rehabilitation and physical therapy to be held in Vienna
6. Media alert: 24th EORTC - NCI - AACR Symposium Molecular Targets and Cancer Therapeutics
7. Symposium on sustainability to feature three new NJIT faculty
8. Key research from the 2012 Breast Cancer Symposium highlights treatment advances for early breast cancer
9. Leading stem cell scientists to focus on diabetes, eye diseases at Cedars-Sinai symposium
10. Penn Translational Medicine Institute to hold 7th Annual Symposium
11. International symposium will address non-Hodgkins lymphoma in the young
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... ... Pregnancy Awareness Month offers a great time to get familiar with the latest ... to have a baby, it’s best to get started before age becomes an issue,” ... & Pregnancy Organizer, written for women who plan on becoming pregnant to learn about ...
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Jonathan Kulbersh of Carolina Facial Plastics isn’t surprised ... five on the list of “ 5 US Cities with the Highest Plastic Rates .” ... and Miami. The results were calculated using a survey by RealSelf and ...
(Date:5/2/2016)... , ... May 02, 2016 , ... The debilitating disease ... and suffering. With no cure, most patients must deal with prescription costs to treat ... card, allowing up to 75% savings at the pharmacy on many common prescriptions. , ...
(Date:5/2/2016)... Ventura, CA (PRWEB) , ... May 02, 2016 ... ... now offering regenerative therapy, which includes amniotic fluid/“stem cells” and Platelet Rich Plasma ... professional athletes and celebrities,” said Dr. James Baranski, D.C., of Advanced Spine & ...
(Date:5/1/2016)... ... 2016 , ... Outdoor Growing Bans Are Sweeping California, which states are next? ... in the hands of the local communities to decide each county’s fate on ... to vote on growing regulations by 3/1/2016 or be forced to follow how the ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
(Date:4/27/2016)... , April 27, 2016 ... titled, "Skincare Devices Market - Global Industry Analysis, Size, ... to the report, the global skincare devices market was ... anticipated to expand at a CAGR of 10.1% from ... 2023. Browse the full Skincare Devices Market (Treatment ...
Breaking Medicine Technology: